Fact CheckerSign in

NCT07622134Not yet recruiting

Effectiveness of Health Literacy Program for Polypharmacy Patients (HLP-CKD)

Effectiveness of the Health Literacy Promotion Program to Prevent Chronic Kidney Disease of Patients Who Use Polypharmacy

Source: ClinicalTrials.gov · Last updated 4 Jun 2026

Brief summary (registry, in English)

This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
104 (estimated)
First submitted
27 May 2026
Start date
15 Jun 2026
Primary completion date
15 Sept 2026
Lead sponsor
Nakhon Pathom Rajabhat University
NCT number
NCT07622134

What you commit to

  • Study type: Interventional
  • Planned participants: 104
  • From 15 Jun 2026 to the primary completion date, 15 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5.
  • Having severe cognitive impairment or psychiatric disorders that prevent participation.
  • Having severe complications or being in an unstable clinical condition.

Other

  • Planning to move out of the study area during the 12-week study period.

Who the study is looking for

  • Patients aged 55-74 years diagnosed with non-communicable diseases.
  • Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
  • Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
  • Able to communicate, read, and write in Thai.
  • Willing to participate in the 8-week program and follow-up assessments.

Age in the registry: 55 years to 74 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Health Promoting Hospital
Coordinator of this site? Confirm its status
Nakhon PathomThailandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.